Beneficiaries of plans that covered fewer than the median number of DMTs in the past year were more likely to have a relapse, ...

Experts from Ciena, CableLabs, and NLM Photonics on whether coherent optics can fix PON’s bandwidth bottleneck ...

Helius Medical Technologies reports positive results from clinical trials of PoNS device for stroke-related gait and balance deficits.

About the PoNS Device and PoNS Therapy The Portable Neuromodulation Stimulator (“PoNS”) is an innovative, non-implantable, orally applied therapy that delivers neurostimulation through a mouthpiece ...

- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another recent authorization by Anthem ...

- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -Th ...

This marks the fifth major commercial healthcare payer to authorize claims for the PoNS device, following a recent similar authorization by Anthem MultiPlan at a negotiated price of $19,160.